Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
about
Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteinsOrthopoxvirus genes that mediate disease virulence and host tropismThe vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infectionImpact of protein kinase PKR in cell biology: from antiviral to antiproliferative actionSubversion of cytokine networks by virally encoded decoy receptorsMAIT cells are activated during human viral infectionsExpression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathwayVirus-induced type I IFN stimulates generation of immunoproteasomes at the site of infectionOncolytic virotherapy for pediatric malignancies: future prospectsMurine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon responseHighly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral stateImproved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsTargeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virusGenome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsInduction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver.An interferon-gamma-binding protein of novel structure encoded by the fowlpox virus.Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.Mechanisms of immune escape in viral hepatitis.Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.Viral modulation of the host response via crmA/SPI-2 expression.Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccinesRole of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic miceSerp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivoEnhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.Poxvirus-induced immunostimulating effects on porcine leukocytes.Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicityExpression of secreted cytokine and chemokine inhibitors by ectromelia virusACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Synergistic interaction between oncolytic viruses augments tumor killing.Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.
P2860
Q21136251-C0BB59DA-8F75-4417-B537-4F0A93637D95Q21285044-884F77CE-EC76-4C26-AEB0-F0CA9007857CQ24527590-296C3C5B-92F9-4640-A912-305C5A6A216FQ24562957-A8993D74-0DD7-492F-B0E6-04B68F90675CQ24672548-A031D403-5599-4611-8396-0B919D29F476Q27005694-FC150638-5897-4066-A57D-9A9FF1187980Q27469032-175F0C34-C2F1-4950-AEBB-23358E336816Q27469729-9C10954D-E270-4BB7-ABC2-8BBD0B2F5012Q27477499-7EF73B45-F14B-4A9F-BE03-9B431A73B8F2Q28069358-E6F5B6BC-2279-43D2-94B2-14FE0935586DQ28115030-E4720294-E9BD-47D8-BD03-F70B5E378CA2Q28131663-3125F50D-FC70-4641-8640-BCC4B7EB8AFDQ28646537-B7659D11-B96D-47A1-AE6C-EB53B084AB7CQ28742751-687F31EA-E60E-4CFF-AA4B-E88325CA9E4CQ28755816-10D03408-1DAA-430C-9740-E622686DC1CBQ28943252-3C051098-8ED7-470A-AB35-0845DECB62D6Q30339052-070A0A96-611B-4B0E-9F43-A520A9DA0823Q31045190-67D4AD22-A5CC-4AD0-BD9C-F807403CE2B1Q31121628-3FF5F693-D835-449B-9A32-2CAC34E2F296Q33187731-E981BAA8-F8B0-4B1A-A97E-55182F4F1254Q33328336-DA1C8EF1-FC63-43BB-A431-267B8856662FQ33429965-63459B82-6FE6-4005-8FFC-C28EE49CBF52Q33594871-FB553DB6-3421-4FB0-919D-AAFDB282E76EQ33602820-51FA823C-20BA-47C0-AF44-4B9F1CC59672Q33641693-18B05F18-F73C-4860-A42B-1B1F405FBFBFQ33653453-C6483331-C82E-4CA9-BC97-533F743F8F3CQ33657931-82CA1744-1A17-43F2-8B7B-100C1DBC7EB1Q33780579-BEBD29B1-4F19-46CE-9A28-0385272048F4Q33782739-2C26834F-6E6B-4329-8E99-414877E0E199Q33782971-1CEF532B-CAEF-4912-9F72-143F488344B1Q33784673-016F9333-44F7-45BD-8C25-EB73CC5412DBQ33801656-51B3774F-2AE1-4107-B800-1392D43A659BQ33808504-B2227183-B0F5-4F52-80C2-68F91C2B9203Q33810581-1C2CC361-49EE-4B42-A5EE-D8BC70063071Q33812636-72A8CD39-DEA7-46F3-953A-176879D1CFFCQ33834391-7FA51B19-6F7C-4634-86E3-61F5B42060A4Q33874093-866A4594-C597-47BA-B202-5C0E63875112Q33892570-3460D8A9-F363-4F19-A3E1-9092ACFD3544Q33931616-D6BAE4BF-9BDB-49B3-A84F-D8E248B80E20Q34014960-263D26B7-B161-4375-8EF7-4FB56FB8AD8A
P2860
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Vaccinia virus encodes a solub ...... and broad species specificity.
@en
Vaccinia virus encodes a solub ...... and broad species specificity.
@nl
type
label
Vaccinia virus encodes a solub ...... and broad species specificity.
@en
Vaccinia virus encodes a solub ...... and broad species specificity.
@nl
prefLabel
Vaccinia virus encodes a solub ...... and broad species specificity.
@en
Vaccinia virus encodes a solub ...... and broad species specificity.
@nl
P1433
P1476
Vaccinia virus encodes a solub ...... and broad species specificity.
@en
P2093
P304
P356
10.1016/0092-8674(95)90076-4
P407
P577
1995-05-01T00:00:00Z